(Q45880240)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15616600%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

title

Combined ionizing radiation and sKDR gene delivery for treatment of prostate carcinomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15616600%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15616600%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Kaliberov SA

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15616600%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Kaliberova LN

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15616600%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

1 March 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15616600%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15616600%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15616600%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15616600%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

407-417

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15616600%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302432

6 January 2020

exact match

0 references

cites work

Current strategies in the management of hormone refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

Radical radiotherapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

Combining radiotherapy with gene therapy (from the bench to the bedside): a novel treatment strategy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

Prodrug activation gene therapy and external beam irradiation in the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

Ionizing radiation greatly improves gene transfer efficiency in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

High-efficiency stable gene transfer of adenovirus into mammalian cells using ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

Sustained enhancement of liposome-mediated gene delivery and gene expression in human breast tumour cells by ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

VEGF receptor subtypes KDR and FLT1 show different sensitivities to heparin and placenta growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

Novel therapeutic strategies in prostate cancer management using gene therapy in combination with radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

Radiation therapy for the treatment of locally advanced and metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

An analysis of microvessel density, androgen receptor, p53 and HER-2/neu expression and Gleason score in prostate cancer . preliminary results and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

What's new in the treatment of advanced prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

Ionizing radiation modulates vascular endothelial growth factor (VEGF) expression through multiple mitogen activated protein kinase dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

Combined-modality treatment of solid tumors using radiotherapy and molecular targeted agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

Tumour-endothelium interactions in co-culture: coordinated changes of gene expression profiles and phenotypic properties of endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

Adenovirus-mediated transfer of BAX driven by the vascular endothelial growth factor promoter induces apoptosis in lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

Specificity of vascular endothelial cell growth factor receptor ligand binding domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

7 January 2021

Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

7 January 2021

Tumor response to radiotherapy regulated by endothelial cell apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

7 January 2021

An autocrine loop mediates expression of vascular endothelial growth factor in human dermal microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

7 January 2021

Vascular endothelial growth factor (VEGF) activates Raf-1, mitogen-activated protein (MAP) kinases, and S6 kinase (p90rsk) in cultured rat cardiac myocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

7 January 2021

Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302432

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302432

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15616600%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

6 January 2020

0 references

1 reference